Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
06/2007
06/20/2007EP1796678A2 Carboxamide spirolactam cgrp receptor antagonists
06/20/2007EP1796669A2 Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
06/20/2007EP1611094B1 Pyrazole compounds
06/20/2007EP1610786B1 4-(4-(heterocyclylalkoxy phenyl)-1-(heterocyclyl-carbonyl)piperidine derivatives and related compounds as histamine h3 antagonists for the treatment of neurological diseases such as alzheimer's
06/20/2007EP1556358B1 Enantioselective alkylation of tricyclic compounds
06/20/2007EP1487824B1 Diamino-pyrimidines and their use as angiogenesis inhibitors
06/20/2007EP1383762B1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same
06/20/2007EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
06/20/2007EP1366043B1 2-heteroaryl-3,4-dihydro-2h-pyrrole derivatives and the use thereof as pesticides
06/20/2007CN1984922A Substituted prolines as inhibitors of hepatitis c virus NS3 serine protease
06/20/2007CN1984910A Dimeric compounds of piperidine, piperazine or morpholine or their 7-membered analogs suitabale for the treatment of neurodegenerative disorders
06/20/2007CN1984903A 1 (indole-6-carbonyl-D-phenylglycinyl) -4- (1-methylpiperidin-4-yl) piperazine D-tartrate
06/20/2007CN1984902A 2-substituted pyrimidines, method for their production and their use for controlling pathogenic fungi
06/20/2007CN1984901A Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors.
06/20/2007CN1984900A Indole derivatives having piperidine rings
06/20/2007CN1984892A Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
06/20/2007CN1984660A 4-arylamino-quinazolines as activators of aspartic acid specificity cysteine protease and inducers of apoptosis
06/20/2007CN1984655A Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
06/20/2007CN1982316A Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them
06/20/2007CN1982306A Alpha-substituted-2-methyl-5-nitro-diazole-1-alcohol derivative with optical activity
06/20/2007CN1981761A Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases
06/20/2007CN1321996C Process for preparing 2-iminopyrrolidine derivatives
06/20/2007CN1321994C 1,2,3,6-tetrahydro phthal-imide compound and their preparation and use
06/20/2007CN1321981C New hydroxyindoles, their use as phosphodiesterase 4 inhibitors and method for producing same
06/20/2007CN1321644C Process for making substituted pyrazoles
06/19/2007US7232912 For therapy of cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
06/19/2007US7232910 Reacting 2-(3-Iodo-1H-indazol-6-ylsulfanyl)-N-methyl-benzamide with 2-vinylpyridine in presence of palladium or copper catalyst to form 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-E-[2-(Pyridine-2-yl)ethenyl]indazole
06/19/2007US7232909 Pyridine derivatives
06/19/2007US7232906 Kinase inhibitors; antiinflammatory agents; respiratory system disorders; cardiovascular disorders; antidiabetic agents
06/19/2007US7232836 1-(3-halopyrid-2-yl)-3-substituted-5-((2,4-substituted-6-aminocarbonyl)phenylaminocarbonyl) pyrazoles insecticides
06/19/2007US7232835 3,6-Disubstituted azabicyclo derivatives as muscarinic receptor antagonists
06/19/2007US7232834 Quinolylpropylpiperidine derivatives, intermediates and compositions containing them, and preparation therefor
06/19/2007US7232833 For therapy and prophylaxis of bacterial infections
06/19/2007US7232832 Antibacterial agents
06/19/2007US7232826 Tyrosine kinase inhibitors
06/19/2007US7232825 Drugs for treatment for diseases such as cancer using tyrosine kinases and enzyme inhibitors
06/19/2007US7232819 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase
06/14/2007WO2007067994A1 Inhibitors of histone deacetylase for the treatment of disease
06/14/2007WO2007067993A1 Inhibitors of histone deacetylase for the treatment of disease
06/14/2007WO2007067844A1 Process for making 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6h-di pyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
06/14/2007WO2007067836A2 Substituted pyrazole compounds useful as soluble epoxide hydrolase inhibitors
06/14/2007WO2007067629A1 Bradykinin 1 receptor antagonists
06/14/2007WO2007067444A1 Bicyclic compounds with kinase inhibitory activity
06/14/2007WO2007067128A1 New process for the preparation of esomeprazole non-salt form
06/14/2007WO2007066601A1 Pyridazine compound and use thereof
06/14/2007WO2007066202A1 Process for the preparation of 2-(2-pyridylmethyl)-sulfinyl-1h-benzimidazoles
06/14/2007WO2007066102A1 Pyrimidine derivatives
06/14/2007WO2007066099A1 Pyrimidine derivatives
06/14/2007WO2007065948A1 Novel n-sulfamoyl-piperidineamides for the prophylaxis or treatment of obesity and related conditions
06/14/2007WO2007065940A1 Antiproliferative pyrimidyl, fused pyrimidyl and pyrimidyl hydrazones
06/14/2007WO2007065916A1 Isoquinoline derivatives
06/14/2007WO2007065913A1 Novel quinazoline-2,4-diamine derivatives and their use as modulators of small-conductance calcium-activated potassium channels
06/14/2007WO2007065669A1 Biaryl compounds useful as agonists of the gpr38 receptor
06/14/2007WO2007065662A2 Trisubstituted quinazolinone derivatives as vanilloid antagonists
06/14/2007WO2007065261A1 Plasminogen activator inhibitor-1 inhibitors
06/14/2007WO2007050375A3 Piperazine derivatives useful as ccr5 antagonists
06/14/2007WO2007036713A3 Chemical process
06/14/2007WO2007035372A3 Polymorphs of benzoate salt of 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor
06/14/2007WO2007007903A3 Carboxamide compound and use of the same
06/14/2007WO2007002462A3 Crystalline forms of mc4r agonist and process for synthesis
06/14/2007WO2006099379A3 Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors
06/14/2007WO2005051308A3 Methods of treating diseases and disorders by targeting multiple kinases
06/14/2007WO2004043335A3 Methods of treating infection by drug resistant bacteria
06/14/2007US20070135505 Aralkyl ester soft drugs
06/14/2007US20070135502 Heterocyclic compounds and methods of use
06/14/2007US20070135488 Amlodipine nicotinate and process for the preparation thereof
06/14/2007US20070135484 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor
06/14/2007US20070135479 Isoquinoline derivatives
06/14/2007US20070135477 Benzimidazole derivatives and their use as protein kinases inhibitors
06/14/2007US20070135475 Process for the preparation of ccr-2 antagonists
06/14/2007US20070135468 Pyridyloxyalkanoic acid amide derivatives useful as fungicides
06/14/2007US20070135464 Antiinflammation agents
06/14/2007US20070135445 Bicyclic Indolyl Derivatives and Methods for Their Use as Serotonergic Agents
06/14/2007US20070135444 Treatment of neuroblastoma
06/14/2007US20070135433 Imidazole derivatives as raf kinase inhibitors
06/14/2007US20070135431 Inhibitors of histone deacetylase for the treatment of disease
06/14/2007US20070135428 Lactam containing cyclic diamines and derivatives as factor xa inhibitors
06/14/2007US20070135426 1-(3-chlorophenyl)-7-oxo-6-[4-(2-oxo-1(2H)pyridinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide; thromboembolic disorder like deep vein thrombosis or pulmonary embolism; pyrazolo[3,4-c]pyridine derivatives; blood coagulation factor (trypsin-like serine protease enzymes) inhibitors
06/14/2007US20070135423 E-fluoro-4-(pyridin-2-yl)-piperidine-1-carboxamide derivatives and related compounds which modulate the function of the vanilloid-1 receptor (vr1) for the treatment of pain
06/14/2007US20070135422 Nitrogen-containing bicycle heterocycles for use as antibacterials
06/14/2007US20070135418 Compositions and methods relating to novel compounds and targets thereof
06/14/2007US20070135409 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
06/14/2007US20070135404 e.g. N-[1-(2-aminoethyl)-4-piperidinyl]-7-methyl-3-(8-quinolinylmethyl)-3H-imidazo[4,5-b]pyridin-2-amine tetrahydrochloride trihydrate; immunostimulant; lower respiratory tract illness during infancy and childhood, asthma, pneumonia
06/14/2007US20070135403 Substituted 2,5-diaminomethyl-1H-pyrrole compounds
06/14/2007US20070135402 Azetidine ring compounds and drugs comprising the same
06/14/2007US20070135353 Crystalline n-formyl hydroxylamine compounds
06/14/2007US20070135346 Prodrugs of CC-1065 analogs
06/14/2007US20070134729 Novel antibacterial agents
06/14/2007US20070134161 Methods of determining beta-iii tubulin expression
06/14/2007DE102005059479A1 Hydroxychinolinderivate Hydroxyquinoline
06/14/2007DE102005059470A1 Insektizide Zusammensetzungen mit verbesserter Wirkung Insecticidal compositions having improved activity
06/14/2007CA2632719A1 Novel n-sulfamoyl-piperidineamides for the prophylaxis or treatment of obesity and related conditions
06/14/2007CA2632643A1 Chemical compounds
06/14/2007CA2632512A1 Bicyclic compounds with kinase inhibitory activity
06/14/2007CA2632212A1 Plasminogen activator inhibitor-1 inhibitors
06/14/2007CA2631919A1 New process for the preparation of esomeprazole non-salt form
06/14/2007CA2631438A1 Trisubstituted quinazolinone derivatives as vanilloid antagonists
06/14/2007CA2631291A1 Antiproliferative pyrimidyl, fused pyrimidyl and pyridyl hydrazones
06/14/2007CA2631037A1 Bradykinin 1 receptor antagonists
06/14/2007CA2630233A1 Substituted pyrazole compounds useful as soluble epoxide hydrolase inhibitors